Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Summary
- Conditions
- Metastatic Colorectal Cancer
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Colorectal cancer is one of the most common malignant tumors, with the morbidity of approximate 100 million cases per year. About 40% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and about 25% of patients with local lesion will ultimately develop metasta...
Colorectal cancer is one of the most common malignant tumors, with the morbidity of approximate 100 million cases per year. About 40% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and about 25% of patients with local lesion will ultimately develop metastatic disease.Therefore, our study is designed to investigate that colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.
Tracking Information
- NCT #
- NCT02043821
- Collaborators
- Not Provided
- Investigators
- Study Director: Guangyu An, PhD Beijing Chao Yang Hospital
Get Well Soon